Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: A case report

Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: A case report

Abstract Background Doege–Potter syndrome is defined as paraneoplastic hypoinsulinemic hypoglycemia associated with a benign or malignant solitary fibrous tumor frequently located in pleural, but also extrapleural sites. Hypoglycemia can be attributed to paraneoplastic secretion of “Big‐IGF‐II,” a p...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Felix Schöler, Maximilian Andreas Storz, Ashkan Khavaran, Nicolas Hümmler, Maximilian Frederik Russe, Christoph‐Ferdinand Wielenberg, Katharina Laubner, Jochen Seufert
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Wiley 2024-03-01
Sarja:Cancer Reports
Aiheet:
debulking surgery
Doege–Potter syndrome
insulin‐like growth factor II
Lanreotide
Octreotide
solitary fibrous tumor
Linkit:https://doi.org/10.1002/cnr2.1992

Internet

https://doi.org/10.1002/cnr2.1992

Samankaltaisia teoksia